Template:Atorvastatin: Difference between revisions

Latest revision as of 20:56, 30 January 2014

Atorvastatin
Lipitor^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

@@ Line 1: / Line 1: @@
-__NOTOC__
+{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
-{{Atorvastatin}}
+! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Atorvastatin|{{fontcolor|#6C7B8B|Atorvastatin}}]]'''''
-{{CMG}} ; {{AE}} , {{PB}}
+|-
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Lipitor<sup>®</sup> FDA Package Insert
+|-
-'''''For patient information, click <u>[[Abciximab (patient information)|here]]'''''</u>.
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin indications and usage|Indications and Usage]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin dosage and administration|Dosage and Administration]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin dosage forms and strengths|Dosage Forms and Strengths]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin contraindications|Contraindications]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin warnings and precautions|Warnings and Precautions]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin adverse reactions|Adverse Reactions]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin drug interactions|Drug Interactions]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin use in specific populations|Use in Specific Populations]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin overdosage|Overdosage]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin description|Description]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin clinical pharmacology|Clinical Pharmacology]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin nonclinical toxicology|Nonclinical Toxicology]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin clinical studies|Clinical Studies]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin how supplied storage and handling|How Supplied/Storage and Handling]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin patient counseling information|Patient Counseling Information]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Atorvastatin labels and packages|Labels and Packages]]
+|-
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
+|-
+|}

Template:Atorvastatin: Difference between revisions

Latest revision as of 20:56, 30 January 2014

Navigation menu